{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:52:02Z","timestamp":1791395522353,"version":"4.3.3"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03432-1","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:09:03Z","timestamp":1791349743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ferroptosis and tumor microenvironment: orchestrating therapy resistance, immune evasion, and metastatic events"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8059-5571","authenticated-orcid":false,"given":"Mohammad Fahad","family":"Ullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"issue":"3","key":"3432_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3432_CR2","doi-asserted-by":"publisher","first-page":"e15699","DOI":"10.1200\/JCO.2025.43.16_suppl.e15699","volume":"43","author":"P Chaulagain","year":"2025","unstructured":"Chaulagain P, Arif T, Xing J, Jain E, Atunde F, Epner E. Shifts in the landscape of colorectal cancer burden: A systematic analysis using the global burden of disease and SEER databases. J Clin Oncol. 2025;43:e15699\u201315699.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3432_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s44197-023-00109-0","volume":"13","author":"G Cao","year":"2023","unstructured":"Cao G, Liu J, Liu M, Global. Regional, and National Trends in Incidence and Mortality of Primary Liver Cancer and Its Underlying Etiologies from 1990 to 2019: Results from the Global Burden of Disease Study 2019. J Epidemiol Glob Health. 2023;13(2):344\u201360.","journal-title":"J Epidemiol Glob Health"},{"key":"3432_CR4","doi-asserted-by":"publisher","first-page":"105066","DOI":"10.1016\/j.critrevonc.2025.105066","volume":"218","author":"D Zhang","year":"2026","unstructured":"Zhang D, Zhao Y, Guo D. Application and potential of the tumor microenvironment, ferroptosis, cuproptosis, and disulfidptosis in cancer treatment and monitoring. Crit Rev Oncol Hematol. 2026;218:105066.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"3432_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4161\/cbt.4.2.1508","volume":"4","author":"Z Jin","year":"2005","unstructured":"Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther. 2005;4(2):139\u201363.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"3432_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5009\/gnl18486","volume":"14","author":"S Aizawa","year":"2020","unstructured":"Aizawa S, Brar G, Tsukamoto H. Cell Death and Liver Disease. Gut Liver. 2020;14(1):20\u20139.","journal-title":"Gut Liver"},{"issue":"12","key":"3432_CR7","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.3390\/cells9122709","volume":"9","author":"Y Woo","year":"2020","unstructured":"Woo Y, Lee HJ, Jung YM, Jung YJ. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies. Cells. 2020;9(12):2709.","journal-title":"Cells"},{"issue":"7","key":"3432_CR8","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3390\/biomedicines13071745","volume":"13","author":"PC Hsu","year":"2025","unstructured":"Hsu PC, Tsai CC, Lin YH, Kuo CY. Therapeutic Targeting of Apoptosis, Autophagic Cell Death, Necroptosis, Pyroptosis, and Ferroptosis Pathways in Oral Squamous Cell Carcinoma: Molecular Mechanisms and Potential Strategies. Biomedicines. 2025;13(7):1745.","journal-title":"Biomedicines"},{"issue":"1","key":"3432_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3892\/or.2025.9029","volume":"55","author":"N Mouawad","year":"2026","unstructured":"Mouawad N, El Jaafari N, El Sibai M, Abi-Habib RJ. Harnessing ferroptosis for cancer therapy: Mechanisms and therapeutic strategies (Review). Oncol Rep. 2026;55(1):24. https:\/\/doi.org\/10.3892\/or.2025.9029.","journal-title":"Oncol Rep"},{"issue":"7","key":"3432_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41419-023-05978-8","volume":"14","author":"S Lee","year":"2023","unstructured":"Lee S, Hwang N, Seok BG, Lee S, Lee SJ, Chung SW. Autophagy mediates an amplification loop during ferroptosis. Cell Death Dis. 2023;14(7):464.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3432_CR11","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s12672-024-01736-0","volume":"15","author":"L Li","year":"2024","unstructured":"Li L, He S. Programmed cell death pathways in lung adenocarcinoma: illuminating tumor drug resistance and therapeutic opportunities through single-cell analysis. Discov Oncol. 2024;15(1):828.","journal-title":"Discov Oncol"},{"issue":"5","key":"3432_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.trecan.2024.01.013","volume":"10","author":"E Catanzaro","year":"2024","unstructured":"Catanzaro E, Demuynck R, Naessens F, Galluzzi L, Krysko DV. Immunogenicity of ferroptosis in cancer: a matter of context? Trends Cancer. 2024;10(5):407\u201316.","journal-title":"Trends Cancer"},{"issue":"20","key":"3432_CR13","doi-asserted-by":"publisher","first-page":"9902","DOI":"10.3390\/ijms26209902","volume":"26","author":"A Szulc","year":"2025","unstructured":"Szulc A, Wo\u017aniak M. Targeting Ferroptosis as the Achilles\u2019 Heel of Breast Cancer: Mechanisms and Therapeutic Opportunities from a Comprehensive Systematic Review. Int J Mol Sci. 2025;26(20):9902.","journal-title":"Int J Mol Sci"},{"key":"3432_CR14","doi-asserted-by":"publisher","first-page":"910292","DOI":"10.3389\/fphar.2022.910292","volume":"13","author":"FJ Li","year":"2022","unstructured":"Li FJ, Long HZ, Zhou ZW, Luo HY, Xu SG, Gao LC. System Xc\u2013\/GSH\/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front Pharmacol. 2022;13:910292.","journal-title":"Front Pharmacol"},{"issue":"1\u20132","key":"3432_CR15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Stockwell BR. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1\u20132):317\u201331.","journal-title":"Cell"},{"issue":"1","key":"3432_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/ijms24010449","volume":"24","author":"L Rochette","year":"2022","unstructured":"Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y, Vergely C. Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis. Int J Mol Sci. 2022;24(1):449.","journal-title":"Int J Mol Sci"},{"key":"3432_CR17","doi-asserted-by":"publisher","first-page":"1551003","DOI":"10.3389\/fcell.2025.1551003","volume":"13","author":"K Wu","year":"2025","unstructured":"Wu K, Zhao W, Hou Z, Zhang W, Qin L, Qiu J, Wang D, Zhuang L, Xue X, Sun D. Ferritinophagy: multifaceted roles and potential therapeutic strategies in liver diseases. Front Cell Dev Biol. 2025;13:1551003.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"3432_CR18","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.cell.2019.04.024","volume":"177","author":"DR Green","year":"2019","unstructured":"Green DR. The Coming Decade of Cell Death Research: Five Riddles. Cell. 2019;177(5):1094\u2013107.","journal-title":"Cell"},{"issue":"8","key":"3432_CR19","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.3390\/antiox12081590","volume":"12","author":"M Merkel","year":"2023","unstructured":"Merkel M, Goebel B, Boll M, Adhikari A, Maurer V, Steinhilber D, Culmsee C. Mitochondrial Reactive Oxygen Species Formation Determines ACSL4\/LPCAT2-Mediated Ferroptosis. Antioxid (Basel). 2023;12(8):1590.","journal-title":"Antioxid (Basel)"},{"issue":"7\u20139","key":"3432_CR20","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1089\/ars.2023.0237","volume":"39","author":"J Cui","year":"2023","unstructured":"Cui J, Wang Y, Tian X, Miao Y, Ma L, Zhang C, Xu X, Wang J, Fang W, Zhang X. LPCAT3 Is Transcriptionally Regulated by YAP\/ZEB\/EP300 and Collaborates with ACSL4 and YAP to Determine Ferroptosis Sensitivity. Antioxid Redox Signal. 2023;39(7\u20139):491\u2013511.","journal-title":"Antioxid Redox Signal"},{"issue":"7826","key":"3432_CR21","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2732-8","volume":"585","author":"Y Zou","year":"2020","unstructured":"Zou Y, Henry WS, Ricq EL, Graham ET, Phadnis VV, Maretich P, Paradkar S, Boehnke N, Deik AA, Reinhardt F, Eaton JK, Ferguson B, Wang W, Fairman J, Keys HR, Dan\u010d\u00edk V, Clish CB, Clemons PA, Hammond PT, Boyer LA, Weinberg RA, Schreiber SL. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature. 2020;585(7826):603\u20138.","journal-title":"Nature"},{"key":"3432_CR22","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.2147\/CMAR.S551549","volume":"17","author":"X Zhang","year":"2025","unstructured":"Zhang X, Zhang Y, Wei J, Li X, Jiang A, Shen Y, Hou Y, Liu Q. The Role of SLC7A11 in Tumor Progression and the Regulation Mechanisms Involved in Ferroptosis. Cancer Manag Res. 2025;17:2393\u2013401.","journal-title":"Cancer Manag Res"},{"issue":"23","key":"3432_CR23","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1158\/0008-5472.CAN-24-4949","volume":"85","author":"HM Zhou","year":"2025","unstructured":"Zhou HM, Liu Y, Shi F, Qiu HW, Li L, Shu QP, Liu YY, Wang BQ, Gao M, Du RL, Ke SB, Zhang XD. CLK2 Regulates the KEAP1\/NRF2 and p53 Pathways to Suppress Ferroptosis in Colorectal Cancer. Cancer Res. 2025;85(23):4734\u201350.","journal-title":"Cancer Res"},{"issue":"7998","key":"3432_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41586-023-06878-9","volume":"626","author":"FP Freitas","year":"2024","unstructured":"Freitas FP, Alborzinia H, Dos Santos AF, Nepachalovich P, Pedrera L, Zilka O, Inague A, Klein C, Aroua N, Kotschi S, Lohr A, Karges J, Ying Y, Chen Q, da Silva HRG, Abdelfatah S, von Kries JP, Dolga A, Egenolf N, Fereidoonnezhad M, Klatt S, Hadian K, Gerecke C, Lenhof HP, Gehring T, M\u00fcller T, Koeberle A, de Oliveira GP, Ke B, Chen F, Weiger TM, W\u00f6lfling J, Kurzchalia T, Bornkessel C, Angeli JPF, Conrad M. 7-Dehydrocholesterol is an endogenous suppressor of ferroptosis. Nature. 2024;626(7998):401\u201310.","journal-title":"Nature"},{"key":"3432_CR25","doi-asserted-by":"crossref","first-page":"104628","DOI":"10.1016\/j.critrevonc.2025.104628","volume":"208","author":"H Jia","year":"2025","unstructured":"Jia H, Bian C, Chang Y. Exploring the molecular interactions between ferroptosis and the Wnt\/\u03b2-catenin signaling pathway. Crit Rev Oncol Hematol. 2025;208:104628.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"3432_CR26","first-page":"228","volume":"15","author":"S Iluta","year":"2025","unstructured":"Iluta S, et al. Notch and Hedgehog Signaling: Crosstalk in Cancer Stem Cell Research. Life (Basel). 2025;15(2):228.","journal-title":"Life (Basel)"},{"issue":"1","key":"3432_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12672-025-04259-4","volume":"17","author":"H Farah","year":"2025","unstructured":"Farah H, Abdulsahib WK, Ismael SH, Roopashree R, Ray S, Nandhini SU, Arora V, Chauhan AS, Buriyeva D. Emerging small molecule strategies target cancer stem cells through ferroptosis and metabostemness. Discov Oncol. 2025;17(1):111.","journal-title":"Discov Oncol"},{"issue":"6","key":"3432_CR28","doi-asserted-by":"publisher","first-page":"sxaf024","DOI":"10.1093\/stmcls\/sxaf024","volume":"43","author":"T Ando","year":"2025","unstructured":"Ando T, Yamasaki J, Saya H, Nagano O. CD44: a key regulator of iron metabolism, redox balance, and therapeutic resistance in cancer stem cells. Stem Cells. 2025;43(6):sxaf024.","journal-title":"Stem Cells"},{"issue":"1","key":"3432_CR29","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1186\/s12951-025-03796-y","volume":"23","author":"L Ye","year":"2025","unstructured":"Ye L, Zhu J, Wang X, Chen N, Sun Y, Zeng X, Liu S, Yan S. Targeting cancer stem-like cells via cholesterol modulation and ferroptosis induction using a multifunctional nanoplatform to overcome drug resistance. J Nanobiotechnol. 2025;23(1):722.","journal-title":"J Nanobiotechnol"},{"key":"3432_CR30","doi-asserted-by":"publisher","first-page":"e70009","DOI":"10.1002\/mog2.70009","volume":"4","author":"Y Tan","year":"2025","unstructured":"Tan Y, Qin S, Zhang Z, Liu Y, Zhou L, Li B, Nice EC, Zhang Y, Jing J. Unraveling the underlying mechanisms of cancer stem cells in therapeutic resistance for optimizing treatment strategies. MedComm \u2013 Oncol. 2025;4:e70009.","journal-title":"MedComm \u2013 Oncol"},{"key":"3432_CR31","doi-asserted-by":"publisher","first-page":"e70068","DOI":"10.1002\/mog2.70068","volume":"5","author":"Z Wang","year":"2026","unstructured":"Wang Z, Li B, Tang P, et al. Oxidative Stress in the Tumor Immune Microenvironment: Mechanisms and Therapeutic Perspectives. MedComm \u2013 Oncol. 2026;5:e70068.","journal-title":"MedComm \u2013 Oncol"},{"issue":"1","key":"3432_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13046-024-03235-0","volume":"43","author":"K Cui","year":"2024","unstructured":"Cui K, Wang K, Huang Z. Ferroptosis and the tumor microenvironment. J Exp Clin Cancer Res. 2024;43(1):315.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"3432_CR33","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.7150\/thno.89805","volume":"14","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Fang S, Fan B, Xu K, Xu L, Wang L, Zhu L, Chen C, Wu R, Ni J, Wang J. Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer. Theranostics. 2024;14(4):1683\u2013700.","journal-title":"Theranostics"},{"key":"3432_CR34","doi-asserted-by":"publisher","first-page":"1255443","DOI":"10.3389\/fimmu.2023.1255443","volume":"14","author":"Z Lin","year":"2024","unstructured":"Lin Z, Zou S, Wen K. The crosstalk of CD8\u2009+\u2009T cells and ferroptosis in cancer. Front Immunol. 2024;14:1255443.","journal-title":"Front Immunol"},{"issue":"5","key":"3432_CR35","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma X, Xiao L, Liu L, Wang L, Liu X, Du Y, Shi H, Zhang Y, Wang Y, Li F, Liu J, Wang H, Zhao Y, Li Z, Zhang Y, Zhang H, Li J, Wang Z, Li Y, Zhang L, Wu K, Nie Y. CD36-mediated ferroptosis dampens intratumoral CD8\u2009+\u2009T cell effector function and impairs their antitumor ability. Cell Metab. 2021;33(5):1001\u2013e10125.","journal-title":"Cell Metab"},{"issue":"1","key":"3432_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang H, Deng T, Liu R, Ning T, Yang H, Liu D, Zhang Q, Lin D, Ge S, Bai M, Wang X, Zhang L, Li H, Yang Y, Ji Z, Wang H, Ying G, Ba Y. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer. 2020;19(1):43.","journal-title":"Mol Cancer"},{"issue":"7769","key":"3432_CR37","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","volume":"572","author":"J Wu","year":"2019","unstructured":"Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, Chen ZN, Jiang X. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature. 2019;572(7769):402\u20136.","journal-title":"Nature"},{"issue":"1","key":"3432_CR38","doi-asserted-by":"publisher","first-page":"1699375","DOI":"10.1080\/23723556.2019.1699375","volume":"7","author":"WH Yang","year":"2019","unstructured":"Yang WH, Huang Z, Wu J, Ding CC, Murphy SK, Chi JT. Hippo pathway effectors YAP\/TAZ as novel determinants of ferroptosis. Mol Cell Oncol. 2019;7(1):1699375.","journal-title":"Mol Cell Oncol"},{"key":"3432_CR39","doi-asserted-by":"publisher","first-page":"532","DOI":"10.18632\/oncotarget.28750","volume":"16","author":"SS Chauhan","year":"2025","unstructured":"Chauhan SS, Vizzerra AD, Liou H, Flores CE, Snider AJ, Snider JM, Warfel NA. Hypoxia induced lipid droplet accumulation promotes resistance to ferroptosis in prostate cancer. Oncotarget. 2025;16:532\u201344.","journal-title":"Oncotarget"},{"issue":"8096","key":"3432_CR40","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41586-025-09710-8","volume":"649","author":"K Wu","year":"2026","unstructured":"Wu K, Vaughan AJ, Bossowski JP, Hao Y, Ziogou A, Kim SM, Kim TH, Nakamura MN, Pillai R, Mancini M, Rajalingam S, Han M, Nakamura T, Wang L, Chung S, Simeone D, Shackelford D, Kang YP, Conrad M, Papagiannakopoulos T. Targeting FSP1 triggers ferroptosis in lung cancer. Nature. 2026;649(8096):487\u201395.","journal-title":"Nature"},{"issue":"15","key":"3432_CR41","doi-asserted-by":"publisher","first-page":"e2204514","DOI":"10.1002\/advs.202204514","volume":"10","author":"CH Chung","year":"2023","unstructured":"Chung CH, Lin CY, Chen CY, Hsueh CW, Chang YW, Wang CC, Chu PY, Tai SK, Yang MH. Ferroptosis Signature Shapes the Immune Profiles to Enhance the Response to Immune Checkpoint Inhibitors in Head and Neck Cancer. Adv Sci (Weinh). 2023;10(15):e2204514.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"3432_CR42","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1038\/s41467-020-19193-y","volume":"11","author":"PP Yee","year":"2020","unstructured":"Yee PP, Wei Y, Kim SY, Lu T, Chih SY, Lawson C, Tang M, Liu Z, Anderson B, Thamburaj K, Young MM, Wang HG, Wen Z, Wang J, Yang D, Liu J, Wang Y, Li Z, Li Y, Zhang L, Wang H, Zhao Y, Li F, Liu X, Du Y, Shi H, Zhang Y, Wang L, Liu L, Xiao L, Ma X. Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma. Nat Commun. 2020;11(1):5424.","journal-title":"Nat Commun"},{"key":"3432_CR43","doi-asserted-by":"publisher","first-page":"1441338","DOI":"10.3389\/fonc.2024.1441338","volume":"14","author":"GL Lupica-Tondo","year":"2024","unstructured":"Lupica-Tondo GL, Arner EN, Mogilenko DA, Voss K. Immunometabolism of ferroptosis in the tumor microenvironment. Front Oncol. 2024;14:1441338.","journal-title":"Front Oncol"},{"issue":"6","key":"3432_CR44","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1021\/acsbiomaterials.3c01665","volume":"10","author":"W Wang","year":"2024","unstructured":"Wang W, Fu R, Gao R, Luo L, Wang Z, Xue Y, Sun J, Pan M, Hong M, Qiao L, Qiao W, Mei Q, Wu J, Wang Y, Zhong Y, Liu J, Tong F. H2S-Powered Nanomotors for Active Therapy of Tumors by Inducing Ferroptosis and Lactate-Pyruvate Axis Disorders. ACS Biomater Sci Eng. 2024;10(6):3994\u20134008.","journal-title":"ACS Biomater Sci Eng"},{"issue":"5","key":"3432_CR45","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41416-020-01156-1","volume":"124","author":"VDB Bonif\u00e1cio","year":"2021","unstructured":"Bonif\u00e1cio VDB, Pereira SA, Serpa J, Vicente JB. Cysteine metabolic circuitries: druggable targets in cancer. Br J Cancer. 2021;124(5):862\u201379.","journal-title":"Br J Cancer"},{"issue":"19","key":"3432_CR46","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/s41388-025-03318-y","volume":"44","author":"C Zhang","year":"2025","unstructured":"Zhang C, Zhou W, Xu H, Xu J, Li J, Liu X, Lu X, Dai J, Jiang Y, Wang W, Zhang E, Guo R. Cancer-associated fibroblasts promote EGFR-TKI resistance via the CTHRC1\/glycolysis\/H3K18la positive feedback loop. Oncogene. 2025;44(19):1400\u201314.","journal-title":"Oncogene"},{"issue":"1","key":"3432_CR47","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41419-025-08239-y","volume":"16","author":"F Li","year":"2025","unstructured":"Li F, Huang H, Huang Q, Mao X, Cong N, Zhuang W, Hsueh CY, Zhang M. Necrotic and apoptotic adipocytes in the hypoxic tumor microenvironment supply triglycerides to induce cisplatin resistance in the metastatic lymph nodes of head and neck carcinoma. Cell Death Dis. 2025;16(1):854.","journal-title":"Cell Death Dis"},{"issue":"10","key":"3432_CR48","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.32604\/or.2025.067247","volume":"33","author":"S Bei","year":"2025","unstructured":"Bei S, Guo Q, Wu X, Li F, Xie Y, Zhang X, Feng L, Zhang X. HCAR1 Modulates Ferroptosis in Gastric Cancer via Lactate-Mediated AMPK-SCD1 Signaling and Lipid Metabolism. Oncol Res. 2025;33(10):3101\u201325.","journal-title":"Oncol Res"},{"issue":"1","key":"3432_CR49","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1038\/s41467-024-46193-z","volume":"15","author":"F Khan","year":"2024","unstructured":"Khan F, Lin Y, Ali H, Pang L, Dunterman M, Hsu WH, Frenis K, Grant Rowe R, Wainwright DA, McCortney K, Billingham LK, Miska J, Horbinski C, Lesniak MS, Chen P. Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression. Nat Commun. 2024;15(1):1987.","journal-title":"Nat Commun"},{"issue":"42","key":"3432_CR50","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1038\/s41388-022-02460-1","volume":"41","author":"YS Green","year":"2022","unstructured":"Green YS, Ferreira Dos Santos MC, Fuja DG, Reichert EC, Campos AR, Cowman SJ, Acu\u00f1a Pilarte K, Kohan J, Tripp SR, Leibold EA, Sirohi D, Agarwal N, Liu X, Koh MY. ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma. Oncogene. 2022;41(42):4709\u201323.","journal-title":"Oncogene"},{"issue":"12","key":"3432_CR51","doi-asserted-by":"publisher","first-page":"e143691","DOI":"10.1172\/JCI143691","volume":"131","author":"R Singhal","year":"2021","unstructured":"Singhal R, Mitta SR, Das NK, Kerk SA, Sajjakulnukit P, Solanki S, Andren A, Kumar R, Olive KP, Banerjee R, Lyssiotis CA, Shah YM. HIF-2\u03b1 activation potentiates oxidative cell death in colorectal cancers by increasing cellular iron. J Clin Invest. 2021;131(12):e143691.","journal-title":"J Clin Invest"},{"issue":"1","key":"3432_CR52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41420-025-02869-z","volume":"12","author":"K Hu","year":"2025","unstructured":"Hu K, Li J, Chen K, Mi X, Pan Y, Tang J, Cao J, Zhong X. Hypoxia-induced USP13 expression drives ferroptosis resistance and tumor immune evasion in hepatocellular carcinoma through the stabilization of ACLY. Cell Death Discov. 2025;12(1):28.","journal-title":"Cell Death Discov"},{"issue":"3","key":"3432_CR53","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3390\/cancers14030553","volume":"14","author":"A Halama","year":"2022","unstructured":"Halama A, Suhre K. Advancing Cancer Treatment by Targeting Glutamine Metabolism-A Roadmap. Cancers (Basel). 2022;14(3):553.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"3432_CR54","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41419-024-06503-1","volume":"15","author":"C Han","year":"2024","unstructured":"Han C, Ge M, Xing P, Xia T, Zhang C, Ma K, Ma Y, Li S, Li W, Liu X, Zhang B, Zhang L, Zhang L. Cystine deprivation triggers CD36-mediated ferroptosis and dysfunction of tumor infiltrating CD8+ T cells. Cell Death Dis. 2024;15(2):145.","journal-title":"Cell Death Dis"},{"issue":"4","key":"3432_CR55","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, Sell A, Wei S, Grove S, Johnson JK, Kennedy PD, Gij\u00f3n M, Shah YM, Zou W. CD8\u2009+\u2009T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022;40(4):365\u2013e3786.","journal-title":"Cancer Cell"},{"issue":"24","key":"3432_CR56","doi-asserted-by":"publisher","first-page":"13334","DOI":"10.3390\/ijms252413334","volume":"25","author":"H Lyu","year":"2024","unstructured":"Lyu H, Kong J, Chen J, Zhang R, Xiao S, Guo D, Zhang Q, Chen XZ, Tang J, Zhou C. The Emerging Scenario of Ferroptosis in Pancreatic Cancer Tumorigenesis and Treatment. Int J Mol Sci. 2024;25(24):13334.","journal-title":"Int J Mol Sci"},{"key":"3432_CR57","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.immuni.2025.03.002","volume":"58","author":"L Yu","year":"2025","unstructured":"Yu L, Liebenberg K, Shen Y. Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancer. Immunity. 2025;58:909\u2013e9257.","journal-title":"Immunity"},{"issue":"2","key":"3432_CR58","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1097\/JS9.0000000000003946","volume":"112","author":"W Tian","year":"2026","unstructured":"Tian W, Chen K, Deng L, Ding W, Niu X, Feng F, Zhang P. Cancer associated fibroblast exosomal miR-214-3p regulated by hnRNPA2B1 promotes cisplatin resistance by inhibiting ferroptosis. Int J Surg. 2026;112(2):3223\u20133237.","journal-title":"Int J Surg"},{"issue":"6","key":"3432_CR59","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1615\/CritRevImmunol.2025059898","volume":"45","author":"Y Liu","year":"2025","unstructured":"Liu Y, Xu C, Wang Z, Duan K, Chen L, Yu H, Guan J. Microvascular Endothelial Cell-Derived Exosomes Decrease Osteoclastogenesis by Restraining Osteoclast Ferroptosis through the USP13\/NRF2\/GPX4 Pathway. Crit Rev Immunol. 2025;45(6):69\u201381.","journal-title":"Crit Rev Immunol"},{"issue":"1","key":"3432_CR60","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13062-025-00623-0","volume":"20","author":"S Li","year":"2025","unstructured":"Li S, Fu X, Ning D, Liu Q, Zhao J, Cheng Q, Chen X, Jiang L. Colon cancer exosome-associated HSP90B1 initiates pre-metastatic niche formation in the liver by polarizing M1 macrophage into M2 phenotype. Biol Direct. 2025;20(1):52.","journal-title":"Biol Direct"},{"issue":"1","key":"3432_CR61","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41420-024-01905-8","volume":"10","author":"Y Mao","year":"2024","unstructured":"Mao Y, Wang J, Wang Y, Fu Z, Dong L, Liu J. Hypoxia induced exosomal Circ-ZNF609 promotes pre-metastatic niche formation and cancer progression via miR-150-5p\/VEGFA and HuR\/ZO-1 axes in esophageal squamous cell carcinoma. Cell Death Discov. 2024;10(1):133.","journal-title":"Cell Death Discov"},{"issue":"1","key":"3432_CR62","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40164-025-00733-5","volume":"15","author":"Q Lan","year":"2026","unstructured":"Lan Q, Xu H, Zeng Y, Liu L, Hu X, Yang Q, Zhang Y, Liu W, Wu J, Weng J, He J, Xu X, Lai W, Chu Z. PRL-3 up-regulates exosomal ITG\u03b1v\u03b25 expression to promote liver pre-metastatic niche formation and colon cancer liver metastasis. Exp Hematol Oncol. 2026;15(1):6.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"3432_CR63","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/imr.13235","volume":"321","author":"D Tang","year":"2024","unstructured":"Tang D, Kroemer G, Kang R. Ferroptosis in immunostimulation and immunosuppression. Immunol Rev. 2024;321(1):199\u2013210.","journal-title":"Immunol Rev"},{"key":"3432_CR64","doi-asserted-by":"publisher","first-page":"7687","DOI":"10.2147\/JIR.S491885","volume":"17","author":"J Xu","year":"2024","unstructured":"Xu J, Tao L, Jiang L, Lai J, Hu J, Tang Z. Moderate Hypothermia Alleviates Sepsis-Associated Acute Lung Injury by Suppressing Ferroptosis Induced by Excessive Inflammation and Oxidative Stress via the Keap1\/GSK3\u03b2\/Nrf2\/GPX4 Signaling Pathway. J Inflamm Res. 2024;17:7687\u2013704.","journal-title":"J Inflamm Res"},{"key":"3432_CR65","doi-asserted-by":"publisher","first-page":"1344290","DOI":"10.3389\/fonc.2024.1344290","volume":"14","author":"H Zhang","year":"2024","unstructured":"Zhang H, Chen N, Ding C, Zhang H, Liu D, Liu S. Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay. Front Oncol. 2024;14:1344290.","journal-title":"Front Oncol"},{"issue":"1","key":"3432_CR66","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12935-024-03260-1","volume":"24","author":"J Sun","year":"2024","unstructured":"Sun J, Li J, Pantopoulos K, Liu Y, He Y, Kang W, Ye X. The clustering status of detached gastric cancer cells inhibits anoikis-induced ferroptosis to promote metastatic colonization. Cancer Cell Int. 2024;24(1):77.","journal-title":"Cancer Cell Int"},{"issue":"9","key":"3432_CR67","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/s41556-024-01464-1","volume":"26","author":"A Schwab","year":"2024","unstructured":"Schwab A, Rao Z, Zhang J, Gollowitzer A, Siebenk\u00e4s K, Bindel N, D\u2019Avanzo E, van Roey R, Hajjaj Y, \u00d6zel E, Armstark I, Bereuter L, Su F, Grander J, Bonyadi Rad E, Groenewoud A, Engel FB, Bell GW, Henry WS, Angeli JPF, Stemmler MP, Brabletz S, Koeberle A, Brabletz T. Zeb1 mediates EMT\/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition. Nat Cell Biol. 2024;26(9):1470\u201381.","journal-title":"Nat Cell Biol"},{"issue":"10","key":"3432_CR68","doi-asserted-by":"publisher","first-page":"e04602","DOI":"10.1002\/adhm.202504602","volume":"15","author":"S Lin","year":"2026","unstructured":"Lin S, Wang L, Dong X, Wang Z, Cao J, Qi X, Wu L, Zhang J, Shen S. Precision Ferroptosis Amplification via SLC7A11-Directed Proteasomal Degradation for Enhanced Cancer Therapy. Adv Healthc Mater. 2026;15(10):e04602.","journal-title":"Adv Healthc Mater"},{"issue":"13","key":"3432_CR69","doi-asserted-by":"publisher","first-page":"6452","DOI":"10.3390\/ijms26136452","volume":"26","author":"J Lee","year":"2025","unstructured":"Lee J, Seo Y, Roh JL. Emerging Therapeutic Strategies Targeting GPX4-Mediated Ferroptosis in Head and Neck Cancer. Int J Mol Sci. 2025;26(13):6452.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3432_CR70","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10565-025-10010-0","volume":"41","author":"SY Xu","year":"2025","unstructured":"Xu SY, Yin SS, Wang L, Zhong H, Wang H, Yu HY. Insights into emerging mechanisms of ferroptosis: new regulators for cancer therapeutics. Cell Biol Toxicol. 2025;41(1):63.","journal-title":"Cell Biol Toxicol"},{"issue":"1","key":"3432_CR71","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-025-02296-7","volume":"10","author":"D Yu","year":"2025","unstructured":"Yu D, Hu H, Zhang Q, Wang C, Xu M, Xu H, Geng X, Cai M, Zhang H, Guo M, Lu D, Xu H, Li L, Zhang X, Shen R, Lin S, Wang Q, Zhang W, Liu S. Acevaltrate as a novel ferroptosis inducer with dual targets of PCBP1\/2 and GPX4 in colorectal cancer. Signal Transduct Target Ther. 2025;10(1):211.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"3432_CR72","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1158\/1541-7786.MCR-25-0268","volume":"23","author":"J Lesage","year":"2025","unstructured":"Lesage J, DiMauro A, Schab AM, Stidham S, Mullen MM, Fuh KC, Longmore GD. DDR2 Confers Ferroptosis Resistance to Cancer-Associated Fibroblasts and Attenuates PARPi Sensitivity of Ovarian Tumor Cells. Mol Cancer Res. 2025;23(12):1012\u201324.","journal-title":"Mol Cancer Res"},{"issue":"9","key":"3432_CR73","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1002\/1878-0261.70083","volume":"19","author":"E Pardella","year":"2025","unstructured":"Pardella E, Comito G, Ippolito L, Pranzini E, Iozzo M, Gangarossa G, Virgilio F, Bua S, Nocentini A, Sandrini G, Lorito N, Bacci M, Nesi G, Spatafora P, Serni S, Supuran CT, Morandi A, Chiarugi P, Giannoni E. Targeting carbonic anhydrase IX\/XII prevents the anti-ferroptotic effect of stromal lactic acid in prostate carcinoma. Mol Oncol. 2025;19(9):2515\u201336.","journal-title":"Mol Oncol"},{"issue":"1","key":"3432_CR74","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41419-025-07354-0","volume":"16","author":"J Cao","year":"2025","unstructured":"Cao J, Zhou T, Wu T, Lin R, Huang J, Shi D, Yu J, Ren Y, Qian C, He L, Wu G, Dong Z, Yuan S, Gu H. Targeting estrogen-regulated system xc\u2013 promotes ferroptosis and endocrine sensitivity of ER+ breast cancer. Cell Death Dis. 2025;16(1):30.","journal-title":"Cell Death Dis"},{"issue":"5","key":"3432_CR75","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3. rd, Stockwell BR. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"5","key":"3432_CR76","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2174\/1566524022666220509124608","volume":"23","author":"J Yin","year":"2023","unstructured":"Yin J, Meng X, Peng L, Xie W, Liu X, He W, Li S. Ferroptosis and Cancer Immunotherapy. Curr Mol Med. 2023;23(5):401\u20139.","journal-title":"Curr Mol Med"},{"issue":"12","key":"3432_CR77","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1021\/acsbiomaterials.2c00950","volume":"8","author":"SD Jeong","year":"2022","unstructured":"Jeong SD, Jung BK, Lee D, Ha J, Chang HG, Lee J, Lee S, Yun CO, Kim YC. Enhanced Immunogenic Cell Death by Apoptosis\/Ferroptosis Hybrid Pathway Potentiates PD-L1 Blockade Cancer Immunotherapy. ACS Biomater Sci Eng. 2022;8(12):5188\u201398.","journal-title":"ACS Biomater Sci Eng"},{"issue":"3","key":"3432_CR78","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00262-024-03628-2","volume":"73","author":"A Chen","year":"2024","unstructured":"Chen A, Yu Z, Ma N, Lu X, Zhang Y, Xu W, Wang Y, Xie J, Qin Y, Mo G, Wu S, Hou J, Zhu W. Atovaquone enhances antitumor efficacy of TCR-T therapy by augmentation of ROS-induced ferroptosis in hepatocellular carcinoma. Cancer Immunol Immunother. 2024;73(3):49.","journal-title":"Cancer Immunol Immunother"},{"key":"3432_CR79","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2147\/NSA.S550828","volume":"18","author":"M Szwed","year":"2025","unstructured":"Szwed M, Poczta-Krawczyk A, Bukowski K, Marczak A. Nanoparticle-Mediated Ferroptosis for Cancer Therapy: Mechanisms and Therapeutic Strategies. Nanotechnol Sci Appl. 2025;18:445\u201370.","journal-title":"Nanotechnol Sci Appl"},{"issue":"23","key":"3432_CR80","doi-asserted-by":"publisher","first-page":"e2310309","DOI":"10.1002\/advs.202310309","volume":"11","author":"Y Li","year":"2024","unstructured":"Li Y, Liu J, Chen Y, Weichselbaum RR, Lin W. Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy. Adv Sci (Weinh). 2024;11(23):e2310309.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"3432_CR81","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12951-023-02129-1","volume":"21","author":"W Chen","year":"2023","unstructured":"Chen W, Li Z, Yu N, Zhang L, Li H, Chen Y, Gong F, Lin W, He X, Wang S, Wu Y, Ji G. Bone-targeting exosome nanoparticles activate Keap1 \/ Nrf2 \/ GPX4 signaling pathway to induce ferroptosis in osteosarcoma cells. J Nanobiotechnol. 2023;21(1):355.","journal-title":"J Nanobiotechnol"},{"issue":"34","key":"3432_CR82","doi-asserted-by":"publisher","first-page":"e2304407","DOI":"10.1002\/advs.202304407","volume":"10","author":"B Xie","year":"2023","unstructured":"Xie B, Zhao H, Ding YF, Wang Z, Gao C, Li S, Zhang K, Ip SW, Yu H, Wang R. Supramolecularly Engineered Conjugate of Bacteria and Cell Membrane-Coated Magnetic Nanoparticles for Enhanced Ferroptosis and Immunotherapy of Tumors. Adv Sci (Weinh). 2023;10(34):e2304407.","journal-title":"Adv Sci (Weinh)"},{"issue":"42","key":"3432_CR83","doi-asserted-by":"publisher","first-page":"19632","DOI":"10.1039\/D5SC05712D","volume":"16","author":"Y Pang","year":"2025","unstructured":"Pang Y, Luo Y, Liu T, Li Q, Mei L, Zhang J, Li C, Li J, Sun Y. Rationally designed sonocatalyst-enhanced supramolecular ferroptosis inducers for effective cancer therapy. Chem Sci. 2025;16(42):19632\u201343.","journal-title":"Chem Sci"},{"key":"3432_CR84","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41571-026-01128-z","volume":"23","author":"R Kang","year":"2026","unstructured":"Kang R, Liu J, Wang J et al. Translating ferroptosis into oncology: challenges, opportunities and future directions. Nat Rev Clin Oncol 2026;23, 401\u201324.","journal-title":"Nat Rev Clin Oncol"},{"key":"3432_CR85","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/s41568-025-00864-1","volume":"25","author":"A Wahida","year":"2025","unstructured":"Wahida A, Conrad M. Decoding ferroptosis for cancer therapy. Nat Rev Cancer. 2025;25:910\u201324.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"3432_CR86","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3390\/antiox14121411","volume":"14","author":"I Artusi","year":"2025","unstructured":"Artusi I, Rubin M, Cravin G, Cozza G. Ferroptosis in Human Diseases: Fundamental Roles and Emerging Therapeutic Perspectives. Antioxid (Basel). 2025;14(12):1411.","journal-title":"Antioxid (Basel)"},{"issue":"3","key":"3432_CR87","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00204-023-03665-3","volume":"98","author":"K Hou","year":"2024","unstructured":"Hou K, Liu L, Fang ZH, Zong WX, Sun D, Guo Z, Cao L. The role of ferroptosis in cardio-oncology. Arch Toxicol. 2024;98(3):709\u201334.","journal-title":"Arch Toxicol"},{"issue":"1","key":"3432_CR88","doi-asserted-by":"publisher","first-page":"1959977","DOI":"10.1080\/2162402X.2021.1959977","volume":"10","author":"W Zhang","year":"2021","unstructured":"Zhang W, Yao S, Huang H, Zhou H, Zhou H, Wei Q, Bian T, Sun H, Li X, Zhang J, Liu Y. Molecular subtypes based on ferroptosis-related genes and tumor microenvironment infiltration characterization in lung adenocarcinoma. Oncoimmunology. 2021;10(1):1959977.","journal-title":"Oncoimmunology"},{"issue":"1","key":"3432_CR89","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12943-025-02337-3","volume":"24","author":"S Bhowmick","year":"2025","unstructured":"Bhowmick S, Banerjee S, Shridhar V, Mondal S. Reprogrammed immuno-metabolic environment of cancer: the driving force of ferroptosis resistance. Mol Cancer. 2025;24(1):161.","journal-title":"Mol Cancer"},{"issue":"6","key":"3432_CR90","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1080\/17425247.2024.2379937","volume":"21","author":"H Zhou","year":"2024","unstructured":"Zhou H, Cheng Y, Huang Q, Xiao J. Regulation of ferroptosis by nanotechnology for enhanced cancer immunotherapy. Expert Opin Drug Deliv. 2024;21(6):921\u201343.","journal-title":"Expert Opin Drug Deliv"},{"key":"3432_CR91","doi-asserted-by":"publisher","first-page":"1643235","DOI":"10.3389\/fonc.2025.1643235","volume":"15","author":"X Li","year":"2025","unstructured":"Li X, Zhu M, Dong R. Ferroptosis\u2019s Master Switch GPX4 emerges as universal biomarker for precision immunotherapy: a pan-cancer study with in vitro experiments validation. Front Oncol. 2025;15:1643235.","journal-title":"Front Oncol"},{"key":"3432_CR92","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10495-025-02205-x","volume":"31","author":"L Singh","year":"2026","unstructured":"Singh L, Kumar N, Supriya M, et al. Ferroptosis dysregulation, mitochondrial dysfunction, and iron metabolism alterations are correlated with aggressiveness in uveal melanoma. Apoptosis. 2026;31:13.","journal-title":"Apoptosis"},{"key":"3432_CR93","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.freeradbiomed.2022.03.026","volume":"184","author":"Y Luo","year":"2022","unstructured":"Luo Y, Xiang W, Liu Z, et al. Functional role of the SLC7A11-AS1\/xCT axis in the development of gastric cancer cisplatin-resistance by a GSH-dependent mechanism. Free Radic Biol Med. 2022;184:53\u201365.","journal-title":"Free Radic Biol Med"},{"key":"3432_CR94","doi-asserted-by":"publisher","first-page":"1553961","DOI":"10.3389\/fmed.2025.1553961","volume":"12","author":"S Paria","year":"2026","unstructured":"Paria S, Lapides R, Saravi B, Rajagopal A, Torrez AM, K\u00f6lblinger P, Wang-Evers M, Manstein D, Navarini AA, Lazar P, Kem\u00e9ny LV, Sarek G, Adhikari K. N\u00e9meth IB and Roider E. Acyl-CoA synthetase long-chain family member 4\u2014A novel prognostic marker in cutaneous melanoma. Front Med. 2026;12:1553961.","journal-title":"Front Med"},{"key":"3432_CR95","doi-asserted-by":"publisher","first-page":"105646","DOI":"10.1016\/j.ebiom.2025.105646","volume":"114","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Li J, Wang T, Gu X, Li X, Liu Z, Yue W, Li M. VIPAS39 confers ferroptosis resistance in epithelial ovarian cancer through exporting ACSL4. EBioMedicine. 2025;114:105646.","journal-title":"EBioMedicine"},{"issue":"1","key":"3432_CR96","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12915-024-01931-z","volume":"22","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Tao C, Ge Y, Yuan J, Pan F, Lin X, Wang R. A novel single-cell model reveals ferroptosis-associated biomarkers for individualized therapy and prognostic prediction in hepatocellular carcinoma. BMC Biol. 2024;22(1):133.","journal-title":"BMC Biol"},{"issue":"1","key":"3432_CR97","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12943-025-02544-y","volume":"25","author":"F Guo","year":"2026","unstructured":"Guo F, Zong S, Zhang X, Ren Z, Shao H, Li J, Wang X, Li Y, Wang X, Chen K. Ferroptosis and metastasis: molecular checkpoints, microenvironmental dynamics, and therapeutic opportunities. Mol Cancer. 2026;25(1):45.","journal-title":"Mol Cancer"},{"key":"3432_CR98","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41523-024-00685-9","volume":"10","author":"K Hu","year":"2024","unstructured":"Hu K, Qiu J, Hu Y, et al. Efficacy of FERscore in predicting sensitivity to ferroptosis inducers in breast cancer. npj Breast Cancer. 2024;10:74.","journal-title":"npj Breast Cancer"},{"key":"3432_CR99","doi-asserted-by":"publisher","first-page":"739392","DOI":"10.3389\/fcell.2021.739392","volume":"9","author":"Y Liu","year":"2021","unstructured":"Liu Y, Duan C, Dai R, Zeng Y. Ferroptosis-mediated Crosstalk in the Tumor Microenvironment Implicated in Cancer Progression and Therapy. Front Cell Dev Biol. 2021;9:739392.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"3432_CR100","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1158\/0008-5472.CAN-24-0275","volume":"84","author":"R Zhang","year":"2024","unstructured":"Zhang R, Kang R, Tang D. Gut Microbiome Mediates Ferroptosis Resistance for Colorectal Cancer Development. Cancer Res. 2024;84(6):796\u20137.","journal-title":"Cancer Res"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03432-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03432-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03432-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:02:16Z","timestamp":1791392536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03432-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":100,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3432"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03432-1","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"307"}}